U.S. Cannabis Market Size To Reach $76.39 Billion By 2030

U.S. Cannabis Market Growth & Trends

The U.S. cannabis market size is expected to reach USD 76.39 billion by 2030, registering a CAGR of 11.51% from 2025 to 2030, according to a new report by Grand View Research, Inc. Factors such as legalization of medicinal cannabis, growing consumer disposable income, rising demand for cannabis from the pharmaceutical industry, growing consumer awareness of the health benefits of cannabis, presence of major manufacturers, and the approval of the U.S. farm bill are expected to boost the market growth.

Cannabis is generally used for the treatment of various conditions, such as cancer, mental disorders, pain management, & nausea, and for recreational purposes. The high prevalence of cancer is expected to be one of the factors driving the adoption of medical marijuana over the forecast period. For instance, according to an article published by the American Cancer Society in January 2023, 609,820 cancer deaths and 1,958,310 new cancer cases were anticipated to occur in the U.S. In addition to that, two cannabidiol (CBD) drugs namely nabilone and dronabinol are approved by the FDA for the treatment of vomiting and nausea caused by chemotherapy in the U.S.

Rising awareness among people regarding the therapeutic benefits of cannabis and the launch of cannabis certification programs through partnerships drives market growth. For instance, in December 2023, Bellarmine University introduced a cannabis education certificate program offered by a public Kentucky University focusing on agriculture, business, medicine, and law in the fast-changing cannabis industry.

With the legalization of cannabis in different areas of the U.S. for medical & recreational use, many well-known personalities and mainstream companies are seeking to benefit from this trend. For instance, celebrities such as Jay-Z and Snoop Dogg have joined this movement by launching branded cannabis products (Monogram). However, avid cannabis consumers seek information regarding the extent of the celebrity’s involvement in the cultivation process. Despite this scrutiny, more celebrities are expected to follow this trend and enter the cannabis cultivation industry.

New technologies and improvements are continually being developed for the cultivation of cannabis. With an increasing demand for technologically advanced cannabis production, these expanded techniques are anticipated to assist cultivators in optimizing their resources, which further drives the market growth.

 Request a free sample copy or view report summary: U.S. Cannabis Market Report

U.S. Cannabis Market Report Highlights

• The marijuana segment dominated the market with the highest revenue share of 87.7% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The hemp segment is anticipated to grow at a significant CAGR from 2025 to 2030.

• The CBD segment dominated the market with the largest revenue share of 63.3% in 2024. CBD is the non-psychoactive compound found in the cannabis plant, and its adoption is increasing for a wide range of health issues.

• The indoor cultivation segment dominated the market with the largest revenue share of 54.8% in 2024 and is expected to grow at the fastest CAGR over the forecast period. The outdoor cultivation segment held a significant share in 2024.

• The recreational use segment dominated the market with a revenue share of 66.9% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The medical use segment is anticipated to grow significantly over the forecast period.

U.S. Cannabis Market Segmentation

Grand View Research has segmented U.S. cannabis market report based on source, derivatives, end-use, and cultivation:

U.S. Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)

• Hemp

  • Hemp Oil

  • Industrial Hemp

• Marijuana

  • Flower

  • Oil and Tinctures

U.S. Cannabis Derivatives Outlook (Revenue, USD Million, 2018 - 2030)

• CBD

• THC

• Others

U.S. Cannabis Cultivation Outlook (Revenue, USD Million, 2018 - 2030)

• Indoor Cultivation

• Greenhouse Cultivation

• Outdoor Cultivation

U.S. Cannabis End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Industrial Use

• Medical Use

  • Chronic Pain

  • Depression and Anxiety

  • Arthritis

  • Post-Traumatic Stress Disorder (PTSD)

  • Cancer

  • Migraines

  • Epilepsy

  • Alzheimer’s Disease

  • Multiple Sclerosis

  • AIDS

  • Amyotrophic Lateral Sclerosis

  • Tourette’s Syndrome

  • Diabetes

  • Parkinson's Disease

  • Glaucoma

  • Others

• Recreational Use

List of Key Players in U.S. Cannabis Market

• Medical Marijuana, Inc.

• NuLeaf Naturals, LLC

• CV Sciences, Inc.

• CHARLOTTE’S WEB.

• The Cronos Group

• Organigram Holding, Inc

• Irwin Naturals

• Tilray Brands

• Canopy Growth Corporation

• Aurora Cannabis